FDA Publishes Guidance on Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin

Summary

The FDA is publishing a guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin, in line with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).